Noninvasive Detection of Clinically Occult Lymph Node Metastases in Prostate and Bladder Cancer Evaluated by USPIO-Enhanced MRI and Diffusion-Weighted MRI: A Histopathological Correlation
Interventional
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Discrimination of N positive (N+) vs. N negative (N0) patients (prostate and bladder cancer) using diffusion-weighted imaging, USPIO enhancement and both.
1 year
No
Harriet C Thoeny, MD
Principal Investigator
University Hospital Inselspital, Bern, Switzerland
Switzerland: Swissmedic
SNF320000-113512/1
NCT00622973
September 2007
March 2011
Name | Location |
---|